Industry Insights

21 april 2022

Gene Therapy for Rare Disorders

Of the many medical breakthroughs over the past three decades, few have been as promising as gene therapy.
Read More

explore our insights categories

View All
Biologics
Vaccines
21 april 2022

CEPI awards up to US$21 million to Themis Bioscience for Phase 3 Chikungunya Vaccine Development

CEPI awards US$21 million to Themis Bioscience.
Read More
30 july 2019

COVID-19 Case Analysis 23 Jan to 29 March 2020

Animated bubble plot of cumulative COVID-19 cases & deaths by country.
Read More
30 july 2019

Live Attenuated Viral Vaccines Advancements

Innovation is continually taking place for a generation of new vaccines to meet patient needs across the globe.
Read More
30 july 2019

Hope for Chlamydia STI Vaccine After Promising Initial Results

A vaccine to protect against Chlamydia has taken a step closer to licensure after successful phase 1 clinical trials.
Read More

Supporting Clinical & Pharmaceutical Development

Providing help to organisations globally

Get in touch
Back To Top
contactus@greyrigge.com